| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 355,042 | 416,976 | 373,246 | 532,438 | | Cost of Revenue | 252,348 | 211,237 | 266,384 | 238,383 | | | Gross Profit | 102,694 | 205,739 | 106,862 | 294,055 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,224 | 21,798 | 27,755 | (280) | | Non Recurring |
-
| (482) | 482 | 698,508 | | Others | 28,183 | 66,537 | 52,707 | 42,642 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 43,287 | 117,886 | 25,918 | (446,815) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82,366 | 1,255 | 4,880 | 19,397 | | Earnings Before Interest And Taxes | 37,152 | 119,141 | 30,798 | (8,764) | | Interest Expense | 47,754 | 41,922 | 34,646 | 37,430 | | Income Before Tax | (10,602) | 77,219 | (3,848) | (46,194) | | Income Tax Expense | (708) | 3,270 | 2,993 | (17,282) | | Minority Interest |
-
|
-
|
-
| 418,654 | | | | Net Income From Continuing Ops | (9,894) | 73,949 | (6,841) | (28,912) | | | Non-recurring Events | | Discontinued Operations | 8 | 59,761 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (113,572) | 133,710 | (6,841) | (28,912) | | Preferred Stock And Other Adjustments | 112,858 | (124,342) | 11,484 |
-
| | | Net Income Applicable To Common Shares | ($714) | $9,368 | $4,643 | ($28,912) |
|
0.02% Nasdaq 0.00%
Income Statement
